健康人群甲状腺结节的影响因素及IGF‑1在甲状腺组织中的表达及临床意义

潘欣予; 曹宏; 梁佳; 罗琪凡; 张京伟; 陈芳芳

doi:10.14188/j.1671-8852.2024.0077

您当前的位置：

首页 >

文章列表页 >

健康人群甲状腺结节的影响因素及IGF‑1在甲状腺组织中的表达及临床意义

临床医学研究 | 更新时间：2026-11-05

- 健康人群甲状腺结节的影响因素及IGF‑1在甲状腺组织中的表达及临床意义
- Influencing factors of thyroid nodules in healthy population and expression of IGF‑1 as well as its clinical significance in thyroid tissue
- 武汉大学学报（医学版） 2025年46卷第6期页码：743-748
- 作者机构：
  
  1.武汉大学中南医院，甲状腺乳腺外科，湖北武汉 430071
  2.武汉大学中南医院，病理科，湖北武汉 430071
- 作者简介：
  
  潘欣予，女，2002—，主要从事甲状腺及乳腺疾病研究，E‑mail:panxinyu4015203@163.com
  陈芳芳，女，1984—，医学博士，副主任医师，主要从事甲状腺癌及乳腺癌等相关研究，E‑mail:mailcff@163.com
- 基金信息：
  
  武汉大学创新创业训练项目(S202310486269)
- DOI：10.14188/j.1671-8852.2024.0077
  中图分类号： R736.1
- 收稿：2024-01-29，
  
  纸质出版：2025-06-25
- 稿件说明：
移动端阅览
潘欣予,曹宏,梁佳等.健康人群甲状腺结节的影响因素及IGF‑1在甲状腺组织中的表达及临床意义[J].武汉大学学报（医学版）,2025,46(06):743-748.

PAN Xinyu,CAO Hong,LIANG Jia,et al.Influencing factors of thyroid nodules in healthy population and expression of IGF‑1 as well as its clinical significance in thyroid tissue[J].Medical Journal of Wuhan University,2025,46(06):743-748.
潘欣予,曹宏,梁佳等.健康人群甲状腺结节的影响因素及IGF‑1在甲状腺组织中的表达及临床意义[J].武汉大学学报（医学版）,2025,46(06):743-748. DOI： 10.14188/j.1671-8852.2024.0077.

PAN Xinyu,CAO Hong,LIANG Jia,et al.Influencing factors of thyroid nodules in healthy population and expression of IGF‑1 as well as its clinical significance in thyroid tissue[J].Medical Journal of Wuhan University,2025,46(06):743-748. DOI： 10.14188/j.1671-8852.2024.0077.

摘要

目的

分析健康人群中甲状腺结节检出率及相关影响因素，并检测胰岛素样生长因子（IGF‑1）在甲状腺正常组织及病变组织中的表达，探讨甲状腺结节及甲状腺癌的病因机制，为甲状腺疾病的防治提供理论依据。

方法

回顾性收集武汉大学中南医院2019—2022年体检人群的基本信息及体检数据，根据甲状腺超声结果分为结节组和对照组，分析甲状腺结节检出情况，并采用单因素及多因素分析方法对甲状腺结节检出率的相关影响因素进行分析。从检出甲状腺结节的人群中，选择进行了手术治疗、并经病理确诊的20例结节性甲状腺肿患者和20例甲状腺乳头状癌（PTC）患者作为研究对象，分别检测正常甲状腺组织、结节性甲状腺肿、甲状腺癌组织中IGF‑1的表达水平。

结果

在75 324名受检者中，甲状腺结节检出率为60.1%，其中男、女检出率分别为55.3%、67.1%，各年龄组检出率男性均小于女性（

0.05）。女性、高龄、肥胖为甲状腺结节发生的相关影响因素（

0.05）。IGF‑1在结节性甲状腺肿和PTC中的表达均显著高于正常对照组（

0.05），PTC组IGF‑1表达水平显著高于结节性甲状腺肿组（

0.05）。

结论

2019—2022年湖北省地区健康人群的甲状腺结节检出率较高（60.1%），女性、高龄、肥胖是甲状腺结节发生的相关影响因素。IGF‑1对PTC的发生和发展可能起到潜在的相关作用。

Abstract

Objective

To examine the prevalence of thyroid nodules and associated influencing factors among individuals without pre‑existing health conditions

as well as investigate the expression of insulin‑like growth factor 1（IGF‑1） in both normal and malignant nodules. Furthermore

the research seeks to explore the etiology and mechanisms underlying thyroid nodules and thyroid cancer

with the ultimate goal of establishing a theoretical foundation for the prevention and treatment of thyroid diseases.

Methods

The basic information and physical examination data of the health examination population in Zhongnan Hospital of Wuhan University from 2019 to 2022 were retrospectively collected. According to the results of thyroid ultrasound

the patients were divided into the nodule group and the control group. The detection rate of thyroid nodules was analyzed

and the related influencing factors of thyroid nodules detection rate were analyzed by univariate and multivariate analysis methods. Twenty cases of pathologically confirmed nodular goiter and 20 cases of pathologically confirmed papillary thyroid carcinoma (PTC) were selected from the population with thyroid nodules. The expression levels of IGF‑1 in normal thyroid tissues

nodular goiter and thyroid cancer tissues were detected.

Results

Among the 75 324 subjects included

the detection rate of thyroid nodules was 60.1%

with the rates for male and female subjects being 55.3% and 67.1%

respectively. Furthermore

in all age groups

the detection rate for males was lower than that for females (

0.05). Female

old age and obesity were related influencing factors for thyroid nodules (

0.05). The expression of IGF‑1 in nodular goiter and PTC was significantly higher than that in the normal control group (

0.05). The expression of IGF‑1 in PTC was significantly higher than that in nodular goiter group (

0.05).

Conclusion

From 2019 to 2022

the detection rate of thyroid nodules in the healthy population in Hubei Province was high (60.1%). Female

advanced age and obesity are related influencing factors for the occurrence of thyroid nodules. IGF‑1 may play a potential role in the occurrence and development of PTC.

关键词

Keywords

references

周咏 , 张斌华 . 安徽省某三甲医院医护人员的甲状腺结节检出情况及其影响因素分析 [J ] . 安徽医药 , 2022 , 26 ( 8 ): 1576 ‑ 1579 .

ZHOU Y , ZHANG B H . Detection of thyroid nodules among medical staff in a tertiary hospital of Anhui Province and its influencing factors [J ] . Anhui Med Pharm J , 2022 , 26 ( 8 ): 1576 ‑ 1579 .

GRANI G , SPONZIELLO M , PECCE V , et al . Contemporary thyroid nodule evaluation and management [J ] . J Clin Endocrinol Metab , 2020 , 105 ( 9 ): 2869 ‑ 2883 .

霍立双 , 刘丰雨 , 高琛 , 等 . 我国大陆地区甲状腺结节患病率Meta分析 [J ] . 河北医科大学学报 , 2017 , 38 ( 2 ): 138 ‑ 141 .

HUO L S , LIU F Y , GAO C , et al . Prevalence of thyroid nodules in China's mainland: A Meta‑analysis [J ] . J Hebei Med Univ , 2017 , 38 ( 2 ): 138 ‑ 141 .

ZHENG R S , ZHANG S W , ZENG H M , et al . Cancer incidence and mortality in China, 2016 [J ] . J Natl Cancer Cent , 2022 , 2 ( 1 ): 1 ‑ 9 .

WANG J Y , YU F F , SHANG Y N , et al . Thyroid cancer: Incidence and mortality trends in China, 2005‑2015 [J ] . Endocrine , 2020 , 68 ( 1 ): 163 ‑ 173 .

FAN L L , TAN L , CHEN Y T , et al . Investigation on the factors that influence the prevalence of thyroid nodules in adults in Tianjin, China [J ] . J Trace Elem Med Biol , 2018 , 50 : 537 ‑ 542 .

王东梅 , 周茜 , 霍煜廷 , 等 . 甲状腺结节的影响因素研究进展 [J ] . 中国普通外科杂志 , 2018 , 27 ( 5 ): 635 ‑ 641 .

WANG D M , ZHOU Q , HUO Y T , et al . Research progress of influential factors for thyroid nodules [J ] . Chin J Gen Surg , 2018 , 27 ( 5 ): 635 ‑ 641 .

LIN R T , FOGARTY C E , MA B W , et al . Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis [J ] . BMC Genomics , 2021 , 22 ( 1 ): 576 .

SALMON W D , DAUGHADAY W H . A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro [J ] . J Lab Clin Med , 1957 , 49 ( 6 ): 825 ‑ 836 .

DEMETRIOU E , FOKOU M , FRANGOS S , et al . Thyroid nodules and obesity [J ] . Life , 2023 , 13 ( 6 ): 1292 .

ELSAYED N A , ALEPPO G , ARODA V R , et al . Addendum. 2. Classification and diagnosis of diabetes: Standards of care in diabetes‑2023 [J ] . Diabetes Care , 2023 , 46 ( Suppl 1 ): S19 ‑ S40 .

于钏钏 , 王强 . 2008—2014年我国健康成人甲状腺结节流行特征及影响因素初步分析 [J ] . 环境与健康杂志 , 2016 , 33 ( 5 ): 440 ‑ 443 .

YU C C , WANG Q . An initial analysis on thyroid nodules prevalence and influencing factors of Chinese healthy adults in 2008-2014 [J ] . J Environ Health , 2016 , 33 ( 5 ): 440 ‑ 443 .

董愫 , 宋雪松 , 庞磊 , 等 . 女性甲状腺结节患者性激素水平及其受体表达的研究 [J ] . 中华内分泌外科杂志 , 2017 , 11 ( 1 ): 29 ‑ 33 .

DONG S , SONG X S , PANG L , et al . Expression of sex hormones and their receptors in female patients with different types of thyroid nodules [J ] . Chin J Endocr Surg , 2017 , 11 ( 1 ): 29 ‑ 33 .

YI J W , KIM S J , KIM J K , et al . Upregulation of the ESR 1 gene and ESR ratio ( ESR 1/ ESR 2) is associated with a worse prognosis in papillary thyroid carcinoma: The impact of the estrogen receptor α/β expression on clinical outcomes in papillary thyroid carcinoma patients [J ] . Ann Surg Oncol , 2017 , 24 ( 12 ): 3754 ‑ 3762 .

OSPINA N S , PAPALEONTIOU M . Thyroid nodule evaluation and management in older adults: A review of practical considerations for clinical endocrinologists [J ] . Endocr Pract , 2021 , 27 ( 3 ): 261 ‑ 268 .

李刚 , 张晨阳 . 甲状腺结节发生的影响因素分析 [J ] . 临床医学研究与实践 , 2022 , 7 ( 18 ): 5 ‑ 7 .

LI G , ZHANG C Y . Analysis of influencing factors for the occurrence of thyroid nodules [J ] . Clin Res Pract , 2022 , 7 ( 18 ): 5 ‑ 7 .

刘雅思 , 张先翠 , 谢郁芳 , 等 . 不同BMI体检人群甲状腺结节检出情况和影响因素分析 [J ] . 齐齐哈尔医学院学报 , 2023 , 44 ( 10 ): 972 ‑ 978 .

LIU Y S , ZHANG X C , XIE Y F , et al . The detection condition of thyroid nodule among population with different BMI analysis of its influencing factors [J ] . J Qiqihar Med Univ , 2023 , 44 ( 10 ): 972 ‑ 978 .

赖晓英 , 欧阳平 , 朱宏 , 等 . 甲状腺结节检出情况及影响因素:10年309 576例体检人群分析 [J ] . 南方医科大学学报 , 2020 , 40 ( 2 ): 268 ‑ 273 .

LAI X Y , OUYANG P , ZHU H , et al . Detection rate of thyroid nodules in routine health check‑up and its influencing factors: A 10‑year survey of 309 576 cases [J ] . J South Med Univ , 2020 , 40 ( 2 ): 268 ‑ 273 .

O'NEILL R J , ABD ELWAHAB S , KERIN M J , et al . Association of BMI with clinicopathological features of papillary thyroid cancer: A systematic review and meta‑analysis [J ] . World J Surg , 2021 , 45 ( 9 ): 2805 ‑ 2815 .

FRANCHINI F , PALATUCCI G , COLAO A , et al . Obesity and thyroid cancer risk: An update [J ] . Int J Environ Res Public Health , 2022 , 19 ( 3 ): 1116 .

李雅迪 , 陈彦 . 肥胖与甲状腺癌的相关性及作用机制的研究进展 [J ] . 江苏大学学报(医学版) , 2022 , 32 ( 6 ): 471 ‑ 476 .

LI Y D , CHEN Y . Research progress on the correlation between obesity and thyroid cancer and its mechanism [J ] . J Jiangsu Univ Med Ed , 2022 , 32 ( 6 ): 471 ‑ 476 .

AMIN M N , HUSSAIN M S , SARWAR M S , et al . How the association between obesity and inflammation may lead to insulin resistance and cancer [J ] . Diabetes Metab Syndr , 2019 , 13 ( 2 ): 1213 ‑ 1224 .

HIGASHI Y , GAUTAM S , DELAFONTAINE P , et al . IGF‑1 and cardiovascular disease [J ] . Growth Horm IGF Res , 2019 , 45 : 6 ‑ 16 .

何庆远 , 闫慧明 . 代谢综合征与分化型甲状腺癌的发生及严重程度的相关性 [J ] . 现代肿瘤医学 , 2023 , 31 ( 13 ): 2443 ‑ 2447 .

HE Q Y , YAN H M . Corralation between metabolic symdrome and the occurrence and severity of differentiated thyroid carcinoma [J ] . J Mod Oncol , 2023 , 31 ( 13 ): 2443 ‑ 2447 .

周悦 , 闫爽 . 肥胖与甲状腺癌的关系 [J ] . 医学综述 , 2017 , 23 ( 8 ): 1520 ‑ 1523 .

ZHOU Y , YAN S . Correlation between obesity and thyroid cancer [J ] . Med Recapitul , 2017 , 23 ( 8 ): 1520 ‑ 1523 .

CAO J R , YEE D . Disrupting insulin and IGF receptor function in cancer [J ] . Int J Mol Sci , 2021 , 22 ( 2 ): 555 .

LIU Y J , QIANG W , SHI J , et al . Expression and significance of IGF‑1 and IGF‑1R in thyroid nodules [J ] . Endocrine , 2013 , 44 ( 1 ): 158 ‑ 164 .

XU L , PORT M , LANDI S , et al . Obesity and the risk of papillary thyroid cancer: A pooled analysis of three case‑control studies [J ] . Thyroid , 2014 , 24 ( 6 ): 966 ‑ 974 .

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

甲状腺癌组织miR‑338‑3p、TCF4表达水平及与临床病理特征和预后的关系

甲状腺癌组织中C‑kit、miR‑193b‑3p的表达及临床意义

超声造影对TI⁃RADS 4类甲状腺微小结节定性诊断的临床价值

甲状腺乳头状癌的高频超声诊断价值

核因子红细胞2相关因子2在缺血性脑卒中的机制和相关防治价值